Diabetes Care, Vol 8, Issue 3 235-243, Copyright © 1985 by American Diabetes Association

ARTICLES

The course of peripheral vascular disease in non-insulin-dependent diabetes

K Kreines, E Johnson, M Albrink, GL Knatterud, ME Levin, A Lewitan, W Newberry and FA Rose

The present report is an analysis of the course of peripheral vascular disease (PVD) in 619 patients with non-insulin-dependent diabetes (NIDDM) recruited within 1 yr of diagnosis and followed quarterly for up to 14 yr (X = 10.5 yr). At 13 yr duration, the actuarially determined cumulative risks for intermittent claudication (IC), nonpalpable dorsalis pedis pulse (NPUL), and arterial calcification (CALC) were, respectively, 37.9%, 34.5%, and 60.9% for men and 24.3%, 37.6%, and 32.2% for women. Major amputations (AMP) occurred in only 1.3% of the patients, equivalent to approximately one case per 1000 patients per year. The corresponding incidences of IC, NPUL, and CALC were, respectively, 29, 27, and 47 per 1000 men and 19, 27, and 25 per 1000 women per year. CALC and NPUL were strongly related to mortality. Baseline risk factors with probability levels that suggest a relationship to PVD were, in women, age versus CALC (P less than 0.01), age versus NPUL (P less than 0.05), weight versus NPUL (P less than 0.05), systolic BP versus CALC (P less than 0.01), summed glucose tolerance test versus CALC (P less than 0.01), and triglyceride level versus CALC (P less than 0.05). In men, the only significant risk factors were diminished vibration perception, which was related to NPUL (P less than 0.05), and the serum triglyceride level, which was related to IC (P less than 0.05). In patients who are carefully followed prospectively, IC is far more common, but AMP is far less common than has been generally appreciated. Further studies are needed to clarify the roles of the diverse risk factors that are possibly related.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. E. Norman, W. A. Davis, D. G. Bruce, and T. M.E. Davis Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the fremantle diabetes study. Diabetes Care, March 1, 2006; 29(3): 575 - 580. [Abstract] [Full Text] [PDF]

				G. E. Reiber, D. G. Smith, C. Wallace, K. Sullivan, S. Hayes, C. Vath, M. L. Maciejewski, O. Yu, P. J. Heagerty, and J. LeMaster Effect of Therapeutic Footwear on Foot Reulceration in Patients With Diabetes: A Randomized Controlled Trial JAMA, May 15, 2002; 287(19): 2552 - 2558. [Abstract] [Full Text] [PDF]

				A. I. Adler, R. J. Stevens, A. Neil, I. M. Stratton, A. J. M. Boulton, and R. R. Holman UKPDS 59: Hyperglycemia and Other Potentially Modifiable Risk Factors for Peripheral Vascular Disease in Type 2 Diabetes Diabetes Care, May 1, 2002; 25(5): 894 - 899. [Abstract] [Full Text] [PDF]

				E. Cosson, F. Paycha, P. Tellier, R. N. Sachs, A. Ramadan, J. Paries, J.-R. Attali, and P. Valensi Lower-Limb Vascularization in Diabetic Patients: Assessment by thallium-201 scanning coupled with exercise myocardial scintigraphy Diabetes Care, May 1, 2001; 24(5): 870 - 874. [Abstract] [Full Text]

				C. E Bird, M. H Criqui, A. Fronek, J. O Denenberg, M. R Klauber, and R. D Langer Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing Vascular Medicine, February 1, 1999; 4(1): 15 - 21. [Abstract] [PDF]